Bladder cancer market size to more than triple to over $1.1 billion by 2025
The growth will be driven by the increased incorporation of immunotherapies into treatment algorithms, the launch of new…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Driving Innovation The NDDS Way
The need for a multidisciplinary approach to deliver greater therapeutic results has opened new avenues for growth in the novel…
Bliss GVS Pharma: Overcoming social bias
Bliss GVS Pharma has managed to break through the social bias against suppositories and pessaries in the Sub-Saharan African…
Zim Laboratories: On the growth path
Zim Laboratories' oral disintegrating strips is the latest offering of this Nagpur based company's NDDS portfolio by Usha Sharma
Generating value in generics
Utkarsh Palnitkar, Partner and Head, Infrastructure, Government and Healthcare, Life Sciences, KPMG in India, gives an insight on…
IPM valued at Rs 9,225 crores in March 2017
Domestic companies continued to dominate the market with a 78 per cent share in March 2017
Passing the buck?
Prime Minister Modi’s announcement that his government would ensure doctors prescribed generic medicines stirred a hornet’s nest
Express Pharma (Vol. 12, No. 13) May 1-15, 2017
India's Foremost Pharma & Biotech Magazine
The push towards pure generics: Impact on pharma marketing
Mala Raj, Senior Pharma Marketing and Medical Consultant at PMS Services contemplates the consequences of the generic push on some…
Veeva releases survey on digitalisation in Indian pharma
Reports reveals 66 per cent of respondents believe digital will become core to company strategy over the next three years